Neurosurgical Care Limited
Registered number: 08545543
Balance Sheet
as at 31 March 2025
Notes 2025 2024
£ £
Fixed assets
Investments 50 50
Current assets
Cash at bank and in hand 24,397 31,882
Creditors: amounts falling due within one year 4 (15,829) (15,339)
Net current assets 8,568 16,543
Net assets 12,741 16,593
Capital and reserves
Called up share capital 200 200
Profit and loss account 12,541 16,393
Shareholders' funds 12,741 16,593
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
V. Iyer
Director
Approved by the board on 1 August 2025
Neurosurgical Care Limited
Notes to the Accounts
for the year ended 31 March 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Turnover
Turnover represents the value, net of value added tax, of services provided to customers.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation has been computed to write off the cost of tangible fixed assets over their expected useful lives using the following rates
Office equipment over 3 years
Investments
Investments in unquoted equity instruments are measured at fair value. Changes in fair value are recognised in profit or loss. Fair value is estimated by using a valuation technique.
Debtors
Debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are recognised at transaction price including any transaction costs.
Creditors
Creditors are measured at transaction price (which is usually the invoice price).
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing differences.
2 Employees 2025 2024
Number Number
Average number of persons employed by the company 1 1
3 Tangible fixed assets
Office equipment
£
Cost
At 1 April 2024 9,287
At 31 March 2025 15,441
Depreciation
At 1 April 2024 9,287
At 31 March 2025 11,318
Net book value
At 31 March 2025 4,123
4 Creditors: amounts falling due within one year 2025 2024
£ £
Trade creditors (110) 420
Corporation tax - 237
Directors' loan accounts 15,939 14,682
15,829 15,339
5 Other information
Neurosurgical Care Limited is a private company limited by shares and incorporated in England. Its registered office is:
68 Rosemount Road
Bristol
BS48 1UQ
Neurosurgical Care Limited 08545543 false 2024-04-01 2025-03-31 2025-03-31 VT Final Accounts April 2025 V. Iyer No description of principal activity 08545543 2023-04-01 2024-03-31 08545543 core:WithinOneYear 2024-03-31 08545543 core:ShareCapital 2024-03-31 08545543 core:RetainedEarningsAccumulatedLosses 2024-03-31 08545543 2024-04-01 2025-03-31 08545543 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 08545543 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 08545543 bus:Director40 2024-04-01 2025-03-31 08545543 1 2024-04-01 2025-03-31 08545543 2 2024-04-01 2025-03-31 08545543 countries:England 2024-04-01 2025-03-31 08545543 bus:FRS102 2024-04-01 2025-03-31 08545543 bus:FilletedAccounts 2024-04-01 2025-03-31 08545543 2025-03-31 08545543 core:WithinOneYear 2025-03-31 08545543 core:ShareCapital 2025-03-31 08545543 core:RetainedEarningsAccumulatedLosses 2025-03-31 08545543 core:LandBuildings 2025-03-31 08545543 2024-03-31 08545543 core:LandBuildings 2024-03-31 iso4217:GBP xbrli:pure